These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37071558)

  • 21. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
    Battelino T; Alexander CM; Amiel SA; Arreaza-Rubin G; Beck RW; Bergenstal RM; Buckingham BA; Carroll J; Ceriello A; Chow E; Choudhary P; Close K; Danne T; Dutta S; Gabbay R; Garg S; Heverly J; Hirsch IB; Kader T; Kenney J; Kovatchev B; Laffel L; Maahs D; Mathieu C; Mauricio D; Nimri R; Nishimura R; Scharf M; Del Prato S; Renard E; Rosenstock J; Saboo B; Ueki K; Umpierrez GE; Weinzimer SA; Phillip M
    Lancet Diabetes Endocrinol; 2023 Jan; 11(1):42-57. PubMed ID: 36493795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Jensen MH; Vestergaard P; Hirsch IB; Hejlesen O
    J Diabetes Sci Technol; 2022 Jan; 16(1):106-112. PubMed ID: 32945187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control.
    Yoo JH; Kim JH
    Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
    Ulrich H; Bowen M
    J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis.
    Addepally NS; George N; Martinez-Macias R; Garcia-Saenz-de-Sicilia M; Kim WR; Duarte-Rojo A
    Dig Dis Sci; 2018 Dec; 63(12):3498-3508. PubMed ID: 30159733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How use of continuous glucose monitoring can address therapeutic inertia in primary care.
    Martens TW; Parkin CG
    Postgrad Med; 2022 Aug; 134(6):576-588. PubMed ID: 35584802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Glucose Management Indicator: Time to Change Course?
    Selvin E
    Diabetes Care; 2024 Jun; 47(6):906-914. PubMed ID: 38295402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can flash glucose monitoring improve glucose management for Aboriginal and Torres Strait Islander peoples with type 2 diabetes? A protocol for a randomised controlled trial.
    Hachem M; Hearn T; Kelly R; Eer A; Moore B; Sommerville C; Atkinson-Briggs S; Twigg S; Freund M; O'Neal D; Story D; Brown A; McLean A; Sinha A; Furler J; O'Brien R; Tran-Duy A; Clarke P; Braat S; Koye DN; Eades S; Burchill L; Ekinci E
    Trials; 2024 Jul; 25(1):493. PubMed ID: 39030640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.
    Campos-Náñez E; Breton MD
    J Diabetes Sci Technol; 2017 Nov; 11(6):1196-1206. PubMed ID: 28560900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBA1C AND MEAN GLUCOSE DERIVED FROM SHORT-TERM CONTINUOUS GLUCOSE MONITORING ASSESSMENT DO NOT CORRELATE IN PATIENTS WITH HBA1C >8.
    Yamada E; Okada S; Nakajima Y; Bastie CC; Vatish M; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Okamura T; Ozawa A; Yamada M
    Endocr Pract; 2017 Jan; 23(1):10-16. PubMed ID: 27631849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes.
    Ling J; Ng JKCC; Lau ESH; Ma RCW; Kong APS; Luk AOY; Kwok JSS; Szeto CC; Chan JCN; Chow E
    Kidney Int Rep; 2022 Jun; 7(6):1354-1363. PubMed ID: 35685309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes.
    Akturk HK
    Diabetes Technol Ther; 2024 Jul; 26(7):503-508. PubMed ID: 38300516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Going beyond HbA1c to understand the benefits of advanced diabetes therapies.
    Vigersky RA
    J Diabetes; 2019 Jan; 11(1):23-31. PubMed ID: 30151979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
    Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
    Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
    Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.